Announcements
Drinks
28/3/2024 Research EN
Scope publishes final rating methodology for European Real Estate Rating Methodology
The methodology is now final following a call-for-comments period and will apply to all issuer and debt ratings of European real estate corporates. The methodology might have a limited negative impact on outstanding ratings of one issuer.
26/3/2024 Research EN
German savings and co-operative banks well positioned to face challenges
The strong financial results of Germany's savings and co-operative banks demonstrate a high degree of resilience to current challenges, including continued cost pressures and credit risks, particularly in real estate.
25/3/2024 Research EN
The Wide Angle – European banking to 2030: more vigorous on the digital, more rigorous on risk
The future for European banks looks unmistakably digital and AI-driven. Emerging platform economies and the blurring of cyberspace borders between financial and non-financial businesses will further disrupt incumbent banks’ legacy structures.
22/3/2024 Research EN
Financing fibre: France’s lead over Austria, Germany and Italy points to hidden project risks
Long-term stable cashflows promised by infrastructure projects are increasingly attracting institutional investors, but not all projects are created equal. Fibre networks, one of the newest infrastructure asset classes in Europe, are a case in point.
15/3/2024 Research EN
German banks: systemic crisis unlikely amid persistent concerns about real estate slump
Fears of a real estate crisis engulfing German banks, particularly around US office exposure, have overshadowed their better annual results announced in recent weeks. But there is no immediate risk of a systemic crisis.
13/3/2024 Research EN
Italian banks: no acceleration in deposit repricing but funding pressure set to intensify
Deposit rates are rising slowly, reflecting low competition and a favourable deposit mix, but we expect more pressure in coming quarters, owing to TLTRO III redemptions and competition from retail government bond placements.
13/3/2024 Research EN
Bayer proceeds with caution over restructuring: timing is crucial in any refocus on pharma
Bayer AG’s caution over a possibly far-reaching restructuring of its pharmaceutical and crop-science activities is frustrating shareholders but is understandable given the high stakes involved in restoring the company’s investment case.